{
  "ptid_time": "007_S_4272_2015-10-19",
  "img_path": "/data/qiuhui/data/adni/images/007_S_4272/2015-10-19/t1.nii.gz",
  "img_finding": "Image findings: hippocampal volume measures 5,225 mm³, 30.9% below the reference mean. With a Z-score of -3.01 (0.1th percentile), this represents profound atrophy. ",
  "text_data": "Age is 74.9 years. Gender is Male. Education: 12 years. MMSE: 23.0. MoCA: 20.0. Logical Memory: 7.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.22 SUVR (mild elevated); Amyloid beta: 723.50 pg/mL (normal ); Total tau: 237.50 pg/mL (normal ); Phosphorylated tau: 21.95 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The hippocampal volume shows profound atrophy (Z-score -3.01, 0.1th percentile), strongly suggestive of neurodegeneration. Despite normal CSF biomarkers (Aβ, T-tau, P-tau) and no APOE4 risk allele, the cognitive scores (MMSE 23, MoCA 20) indicate mild impairment, and AV45 (amyloid PET) shows mild elevation, suggesting possible early amyloid deposition.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely amyloid-related, given AV45 elevation, but CSF biomarkers are conflicting).  \n\n**Confidence:** **Medium** (due to discrepancy between CSF biomarkers and AV45, as well as the absence of APOE4).",
  "timestamp": "2025-07-25T21:58:44.648936"
}